Literature DB >> 26483408

Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation.

Dakshina M Jandhyala1, Amrita Ahluwalia2, Jennifer J Schimmel2, Arlin B Rogers3, John M Leong4, Cheleste M Thorpe2.   

Abstract

Infection with enterohemorrhagic Escherichia coli (EHEC) can result in severe disease, including hemorrhagic colitis and the hemolytic uremic syndrome. Shiga toxins (Stx) are the key EHEC virulence determinant contributing to severe disease. Despite inhibiting protein synthesis, Shiga toxins paradoxically induce the expression of proinflammatory cytokines from various cell types in vitro, including intestinal epithelial cells (IECs). This effect is mediated in large part by the ribotoxic stress response (RSR). The Shiga toxin-induced RSR is known to involve the activation of the stress-activated protein kinases (SAPKs) p38 and JNK. In some cell types, Stx also can induce the classical mitogen-activated protein kinases (MAPKs) or ERK1/2, but the mechanism(s) by which this activation occurs is unknown. In this study, we investigated the mechanism by which Stx activates ERK1/2s in IECs and the contribution of ERK1/2 activation to interleukin-8 (IL-8) expression. We demonstrate that Stx1 activates ERK1/2 in a biphasic manner: the first phase occurs in response to StxB1 subunit, while the second phase requires StxA1 subunit activity. We show that the A subunit-dependent ERK1/2 activation is mediated through ZAK-dependent signaling, and inhibition of ERK1/2 activation via the MEK1/2 inhibitors U0126 and PD98059 results in decreased Stx1-mediated IL-8 mRNA. Finally, we demonstrate that ERK1/2 are activated in vivo in the colon of Stx2-intoxicated infant rabbits, a model in which Stx2 induces a primarily neutrophilic inflammatory response. Together, our data support a role for ERK1/2 activation in the development of Stx-mediated intestinal inflammation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26483408      PMCID: PMC4694011          DOI: 10.1128/IAI.00977-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation.

Authors:  Dakshina M Jandhyala; Trisha J Rogers; Anne Kane; Adrienne W Paton; James C Paton; Cheleste M Thorpe
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

2.  Verotoxin-2 activates mitogen-activated protein kinases in bovine adherent peripheral blood mononuclear cells.

Authors:  P Cameron; N Paton; D G E Smith
Journal:  J Comp Pathol       Date:  2011-10-19       Impact factor: 1.311

3.  Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells.

Authors:  S Taga; K Carlier; Z Mishal; C Capoulade; M Mangeney; Y Lécluse; D Coulaud; C Tétaud; L L Pritchard; T Tursz; J Wiels
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

4.  Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.

Authors:  B P Hurley; C M Thorpe; D W Acheson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 5.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  The ERK Cascade: Distinct Functions within Various Subcellular Organelles.

Authors:  Inbal Wortzel; Rony Seger
Journal:  Genes Cancer       Date:  2011-03

7.  MRK, a mixed lineage kinase-related molecule that plays a role in gamma-radiation-induced cell cycle arrest.

Authors:  Eleanore A Gross; Marinella G Callow; Linda Waldbaum; Suzanne Thomas; Rosamaria Ruggieri
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

8.  Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin.

Authors:  John Wong; Logan B Smith; Eli A Magun; Thomas Engstrom; Kirsten Kelley-Howard; Dakshina M Jandhyala; Cheleste M Thorpe; Bruce E Magun; Lisa J Wood
Journal:  Cancer Biol Ther       Date:  2012-10-31       Impact factor: 4.742

9.  A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles.

Authors:  Chu Wang; Eranthie Weerapana; Megan M Blewett; Benjamin F Cravatt
Journal:  Nat Methods       Date:  2013-12-01       Impact factor: 28.547

10.  Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine.

Authors:  Wilson Wong; Xiao-chen Bai; Alan Brown; Israel S Fernandez; Eric Hanssen; Melanie Condron; Yan Hong Tan; Jake Baum; Sjors H W Scheres
Journal:  Elife       Date:  2014-06-09       Impact factor: 8.140

View more
  11 in total

1.  Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a In Vivo and In Vitro.

Authors:  Courtney D Petro; Eszter Trojnar; James Sinclair; Zhi-Mei Liu; Mark Smith; Alison D O'Brien; Angela Melton-Celsa
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

2.  A hemolytic-uremic syndrome-associated strain O113:H21 Shiga toxin-producing Escherichia coli specifically expresses a transcriptional module containing dicA and is related to gene network dysregulation in Caco-2 cells.

Authors:  Silvia Yumi Bando; Priscila Iamashita; Beatriz E Guth; Luis F Dos Santos; André Fujita; Cecilia M Abe; Leandro R Ferreira; Carlos Alberto Moreira-Filho
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

Review 3.  Shiga Toxin Therapeutics: Beyond Neutralization.

Authors:  Gregory Hall; Shinichiro Kurosawa; Deborah J Stearns-Kurosawa
Journal:  Toxins (Basel)       Date:  2017-09-19       Impact factor: 4.546

4.  Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.

Authors:  Daniele Mercatelli; Massimo Bortolotti; Vibeke Andresen; André Sulen; Letizia Polito; Bjørn Tore Gjertsen; Andrea Bolognesi
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

5.  CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.

Authors:  Alline R Pacheco; Jacob E Lazarus; Brandon Sit; Stefanie Schmieder; Wayne I Lencer; Carlos J Blondel; John G Doench; Brigid M Davis; Matthew K Waldor
Journal:  mBio       Date:  2018-06-19       Impact factor: 7.867

6.  Shiga toxin remodels the intestinal epithelial transcriptional response to Enterohemorrhagic Escherichia coli.

Authors:  Alyson R Warr; Carole J Kuehl; Matthew K Waldor
Journal:  PLoS Pathog       Date:  2021-02-02       Impact factor: 6.823

Review 7.  Shiga Toxins as Antitumor Tools.

Authors:  Aude Robert; Joëlle Wiels
Journal:  Toxins (Basel)       Date:  2021-09-28       Impact factor: 4.546

Review 8.  Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli.

Authors:  Su-Bin Hwang; Ramachandran Chelliah; Ji Eun Kang; Momna Rubab; Eric Banan-MwineDaliri; Fazle Elahi; Deog-Hwan Oh
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

Review 9.  Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

Review 10.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.

Authors:  Adrien Joseph; Aurélie Cointe; Patricia Mariani Kurkdjian; Cédric Rafat; Alexandre Hertig
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.